Gerresheimer AGGRRMF 66 Days Inventory is 108.19 as of Aug. 2025, which is 53% above its 10-year median of 70.84. GuruFocus rates GRRMF with a GF Score™ of 66/100 and a GF Value™ of $108.04 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Gerresheimer AG ranks better than 81.04% on this metric.
The historical rank and industry rank for Gerresheimer AG's Days Inventory or its related term are showing as below:
GRRMF'
s Days Inventory Range Over the Past 10 Years
Min: 56.99 Med: 70.84 Max: 100.04
Current: 100.04
During the past 13 years, Gerresheimer AG's highest Days Inventory was 100.04. The lowest was 56.99. And the median was 70.84.
GRRMF's Days Inventory is ranked better than 81.04% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.785
vs GRRMF: 100.04
Gerresheimer AG's Days Inventory
increased
from Aug. 2024 (95.06) to Aug. 2025 (108.19).
It might indicate that Gerresheimer AG's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Gerresheimer AG's Inventory Turnover for the
three
months ended in Aug. 2025 was 0.84.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gerresheimer AG's Inventory-to-Revenue for the
three
months ended in Aug. 2025 was 0.89.
Gerresheimer AG (OTCPK:GRRMF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Gerresheimer AG's Inventory Turnover for the
three
months ended in Aug. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gerresheimer AG's Inventory to Revenue for the
three
months ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Gerresheimer AG Days Inventory Related Terms
Gerresheimer AG Days Inventory Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GRRMF vs ISRG, BDX, MDLN: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's Days Inventory distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (GRRMF) has a Days Inventory of 108.19 as of Aug. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gerresheimer AG and its competitors. This is 53% above median its historical median of 70.84. Over the past decade, Gerresheimer AG's Days Inventory has ranged from 56.99 to 100.04. According to the industry distribution chart, Gerresheimer AG ranks #149 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 19%.
Is Gerresheimer AG's Days Inventory too high?
Gerresheimer AG's current Days Inventory of 108.19 is 53% above median its 10-year median of 70.84. Over the past 10 years, this metric has ranged from a low of 56.99 to a high of 100.04. The Medical Devices & Instruments industry median Days Inventory is 179.79. Gerresheimer AG's value of 108.19 is 39.8% below this industry median. Based on the distribution chart, Gerresheimer AG ranks #149 out of 786 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Gerresheimer AG has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Days Inventory compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #149 out of 786 companies for Days Inventory. This places Gerresheimer AG in the top 19% of its industry — outperforming the majority of peers. The industry median Days Inventory is 179.79. Gerresheimer AG's value of 108.19 is 39.8% below this benchmark. Historically, Gerresheimer AG's own Days Inventory has ranged from 56.99 to 100.04 over the past decade. While the company's 10-year median is 70.84 vs. the industry median of 179.79, Gerresheimer AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.79, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gerresheimer AG's current Days Inventory of 108.19 is 39.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current Days Inventory is 108.19, which is 53% above median its own 10-year median of 70.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $108.04, compared to a current price of $30.73 — trading 71.6% below its estimated fair value. The current Days Inventory is 108.19, which is 53% above median its 10-year median of 70.84 and 39.8% below the Medical Devices & Instruments industry median of 179.79. Gerresheimer AG's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Days Inventory is 108.19 as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $30.73 is trading 71.6% below its estimated GF Value™ of $108.04.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
Days Inventory: 108.19 (53% above median its 10-year median of 70.84)
GF Value™: $108.04 vs. price of $30.73 (71.6% below fair value)
Industry Position: 39.8% below the Medical Devices & Instruments median (#149 of 786)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
66GF Score
Get the complete analysis for GRRMF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
